{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:26:24Z","timestamp":1778502384138,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Program for Gansu Provincial Science Foundation of China","award":["21JR7RA416"],"award-info":[{"award-number":["21JR7RA416"]}]},{"name":"The Program for Gansu Provincial Science Foundation of China","award":["21JR7RA416"],"award-info":[{"award-number":["21JR7RA416"]}]},{"name":"Lanzhou University Second Hospital's \u201cCuiying Technology Innovation\u201d Program","award":["CY2018-ZD02"],"award-info":[{"award-number":["CY2018-ZD02"]}]},{"name":"Lanzhou University Second Hospital's \u201cCuiying Technology Innovation\u201d Program","award":["CY2018-ZD02"],"award-info":[{"award-number":["CY2018-ZD02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glucolipid metabolism plays an important role in the occurrence and development of diabetes mellitus. However, there is limited research on the characteristics of glucolipid metabolism and complications in different subgroups of newly diagnosed diabetes. This study aimed to investigate the characteristics of glucolipid metabolism and complications in novel cluster-based diabetes subgroups and explore the contributions of different glucolipid metabolism indicators to the occurrence of complications and pancreatic function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study included 547 newly diagnosed type 2 diabetes patients. Age, body mass index (BMI), glycated hemoglobin (HbA<jats:sub>1<\/jats:sub>C), homeostasis model assessment-2 beta-cell function (HOMA2-\u03b2), and homeostasis model assessment-2 insulin resistance (HOMA2-IR) were used as clustering variables. The participants were divided into 4 groups by k-means cluster analysis. The characteristics of glucolipid indicators and complications in each subgroup were analyzed. Regression analyses were used to evaluate the impact of glucolipid metabolism indicators on complications and pancreatic function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Total cholesterol (TC), triglycerides (TG), triglyceride glucose index (TyG), HbA<jats:sub>1<\/jats:sub>C, fasting plasma glucose (FPG), and 2-h postprandial plasma glucose (2hPG) were higher in the severe insulin-resistant diabetes (SIRD) and severe insulin-deficient diabetes (SIDD) groups. Fasting insulin (FINS), fasting C-peptide (FCP), 2-h postprandial insulin (2hINS), 2-h postprandial C-peptide (2hCP), and the monocyte-to-high-density lipoprotein cholesterol ratio (MHR) were higher in mild obesity-related diabetes (MOD) and SIRD. 2hCP, FCP, and FINS were positively correlated with HOMA2-\u03b2, while FPG, TyG, HbA<jats:sub>1<\/jats:sub>C, and TG were negatively correlated with HOMA2-\u03b2. FINS, FPG, FCP, and HbA<jats:sub>1<\/jats:sub>C were positively correlated with HOMA2-IR, while high-density lipoprotein (HDL) was negatively correlated with HOMA2-IR. FINS (odds ratio (OR),1.043;95% confidence interval (CI) 1.006\u2009~\u20091.081), FCP (OR,2.881;95%CI 2.041\u2009~\u20094.066), and TyG (OR,1.649;95%CI 1.292\u2009~\u20092.104) contributed to increase the risk of nonalcoholic fatty liver disease (NAFLD); 2hINS (OR,1.015;95%CI 1.008\u2009~\u20091.022) contributed to increase the risk of atherosclerotic cardiovascular disease (ASCVD); FCP (OR,1.297;95%CI 1.027\u2009~\u20091.637) significantly increased the risk of chronic kidney disease (CKD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There were differences in the characteristics of glucolipid metabolism as well as complications among different subgroups of newly diagnosed type 2 diabetes. 2hCP, FCP, FINS, FPG, TyG, HbA<jats:sub>1<\/jats:sub>C, HDL and TG influenced the function of insulin. FINS, TyG, 2hINS, and FCP were associated with ASCVD, NAFLD, and CKD in newly diagnosed T2DM patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01953-6","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T09:21:04Z","timestamp":1700558464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristics of glucolipid metabolism and complications in novel cluster-based diabetes subgroups: a retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Xinrong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"1953_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9467","key":"1953_CR2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","volume":"365","author":"M Stumvoll","year":"2005","unstructured":"Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet (London, England). 2005;365(9467):1333\u201346.","journal-title":"Lancet (London, England)"},{"issue":"8","key":"1953_CR3","doi-asserted-by":"publisher","first-page":"e006400","DOI":"10.1161\/JAHA.117.006400","volume":"6","author":"EYF Wan","year":"2017","unstructured":"Wan EYF, Fung CSC, Yu EYT, Chin WY, Fong DYT, Chan AKC, et al. Effect of multifactorial treatment targets and relative importance of hemoglobin A1c, blood pressure, and low-density lipoprotein-cholesterol on cardiovascular diseases in Chinese primary care patients with type 2 diabetes Mellitus: a population-based retrospective cohort study. J Am Heart Assoc. 2017;6(8):e006400.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1953_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jama.291.3.335","volume":"291","author":"SH Saydah","year":"2004","unstructured":"Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335\u201342.","journal-title":"JAMA"},{"issue":"1\u20132","key":"1953_CR5","first-page":"7","volume":"121","author":"MM Ba\u0142a","year":"2011","unstructured":"Ba\u0142a MM, P\u0142aczkiewicz-Jankowska E, Top\u00f3r-M\u0105dry R, Le\u015bniak W, Jaeschke R, Sieradzki J, et al. Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study. Pol Arch Med Wewn. 2011;121(1\u20132):7\u201317.","journal-title":"Pol Arch Med Wewn"},{"issue":"9","key":"1953_CR6","first-page":"4047","volume":"86","author":"SE Kahn","year":"2001","unstructured":"Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab. 2001;86(9):4047\u201358.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1953_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1953_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.diabres.2018.05.014","volume":"141","author":"N Safai","year":"2018","unstructured":"Safai N, Ali A, Rossing P, Ridderstr\u00e5le M. Stratification of type 2 diabetes based on routine clinical markers. Diabetes Res Clin Pract. 2018;141:275\u201383.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"1953_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","volume":"7","author":"OP Zaharia","year":"2019","unstructured":"Zaharia OP, Strassburger K, Strom A, B\u00f6nhof GJ, Karusheva Y, Antoniou S, et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 2019;7(9):684\u201394.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1953_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","volume":"7","author":"JM Dennis","year":"2019","unstructured":"Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 2019;7(6):442\u201351.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"311","key":"1953_CR11","doi-asserted-by":"publisher","first-page":"311ra174","DOI":"10.1126\/scitranslmed.aaa9364","volume":"7","author":"L Li","year":"2015","unstructured":"Li L, Cheng WY, Glicksberg BS, Gottesman O, Tamler R, Chen R, et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med. 2015;7(311):311ra174.","journal-title":"Sci Transl Med"},{"issue":"7","key":"1953_CR12","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3390\/jcm9072083","volume":"9","author":"H Tanabe","year":"2020","unstructured":"Tanabe H, Saito H, Kudo A, Machii N, Hirai H, Maimaituxun G, et al. Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: a japanese retrospective cohort study. J Clin Med. 2020;9(7):2083.","journal-title":"J Clin Med"},{"issue":"6","key":"1953_CR13","doi-asserted-by":"publisher","first-page":"e3419","DOI":"10.1002\/dmrr.3419","volume":"37","author":"L Bennet","year":"2021","unstructured":"Bennet L, Nilsson C, Mansour-Aly D, Christensson A, Groop L, Ahlqvist E. Adult-onset diabetes in Middle Eastern immigrants to Sweden: Novel subgroups and diabetic complications-The All New Diabetes in Scania cohort diabetic complications and ethnicity. Diabetes Metab Res Rev. 2021;37(6):e3419.","journal-title":"Diabetes Metab Res Rev"},{"key":"1953_CR14","doi-asserted-by":"publisher","first-page":"637945","DOI":"10.3389\/fgene.2021.637945","volume":"12","author":"O Fedotkina","year":"2021","unstructured":"Fedotkina O, Sulaieva O, Ozgumus T, Cherviakova L, Khalimon N, Svietleisha T, et al. Novel Reclassification of Adult Diabetes Is Useful to Distinguish Stages of \u03b2-Cell Function Linked to the Risk of Vascular Complications: the DOLCE study from Northern Ukraine. Front Genet. 2021;12:637945.","journal-title":"Front Genet"},{"issue":"1","key":"1953_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00125-021-05543-y","volume":"65","author":"RB Prasad","year":"2022","unstructured":"Prasad RB, Asplund O, Shukla SR, Wagh R, Kunte P, Bhat D, et al. Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver. Diabetologia. 2022;65(1):65\u201378.","journal-title":"Diabetologia"},{"issue":"8","key":"1953_CR16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/jdi.13494","volume":"12","author":"XF Xiong","year":"2021","unstructured":"Xiong XF, Yang Y, Wei L, Xiao Y, Li L, Sun L. Identification of two novel subgroups in patients with diabetes mellitus and their association with clinical outcomes: a two-step cluster analysis. J Diabetes Investig. 2021;12(8):1346\u201358.","journal-title":"J Diabetes Investig"},{"issue":"9","key":"1953_CR17","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s00125-021-05490-8","volume":"64","author":"RC Slieker","year":"2021","unstructured":"Slieker RC, Donnelly LA, Fitipaldi H, Bouland GA, Giordano GN, \u00c5kerlund M, et al. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study. Diabetologia. 2021;64(9):1982\u20139.","journal-title":"Diabetologia"},{"issue":"11","key":"1953_CR18","doi-asserted-by":"publisher","first-page":"e0207096","DOI":"10.1371\/journal.pone.0207096","volume":"13","author":"T Karpati","year":"2018","unstructured":"Karpati T, Leventer-Roberts M, Feldman B, Cohen-Stavi C, Raz I, Balicer R. Patient clusters based on HbA1c trajectories: A step toward individualized medicine in type 2 diabetes. PLoS One. 2018;13(11):e0207096.","journal-title":"PLoS One."},{"issue":"7","key":"1953_CR19","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1007\/s00125-017-4275-6","volume":"60","author":"A Hulman","year":"2017","unstructured":"Hulman A, Simmons RK, Brunner EJ, Witte DR, F\u00e6rch K, Vistisen D, et al. Trajectories of glycemia, insulin sensitivity, and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. Diabetologia. 2017;60(7):1252\u201360.","journal-title":"Diabetologia"},{"issue":"5","key":"1953_CR20","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.2337\/db09-1199","volume":"59","author":"M Carstensen","year":"2010","unstructured":"Carstensen M, Herder C, Kivim\u00e4ki M, Jokela M, Roden M, Shipley MJ, et al. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes. 2010;59(5):1222\u20137.","journal-title":"Diabetes"},{"issue":"12","key":"1953_CR21","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2337\/dc11-2263","volume":"35","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Carstensen M, Witte DR, Brunner EJ, Shipley MJ, Jokela M, et al. Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. Diabetes Care. 2012;35(12):2540\u20137.","journal-title":"Diabetes Care"},{"issue":"2","key":"1953_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel A, Stefan N, Yu Z, M\u00fchlenbruch K, Drogan D, Joost HG, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62(2):639\u201348.","journal-title":"Diabetes"},{"issue":"4","key":"1953_CR23","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Investig. 2011;121(4):1402\u201311.","journal-title":"J Clin Investig"},{"key":"1953_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/msb.2012.43","volume":"8","author":"R Wang-Sattler","year":"2012","unstructured":"Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012;8:615.","journal-title":"Mol Syst Biol"},{"issue":"9","key":"1953_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00125-019-4959-1","volume":"62","author":"S Eid","year":"2019","unstructured":"Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S, et al. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia. 2019;62(9):1539\u201349.","journal-title":"Diabetologia"},{"issue":"2","key":"1953_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrendo.2012.236","volume":"9","author":"BE Harcourt","year":"2013","unstructured":"Harcourt BE, Penfold SA, Forbes JM. Coming full circle in diabetes mellitus: from complications to initiation. Nat Rev Endocrinol. 2013;9(2):113\u201323.","journal-title":"Nat Rev Endocrinol"},{"key":"1953_CR27","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Executive summary: Standards of medical care in diabetes--2012. Diabetes Care. 2012;35 Suppl 1(Suppl 1):S4\u201310.","DOI":"10.2337\/dc12-s004"},{"issue":"7","key":"1953_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353.","journal-title":"Diabet Med"},{"issue":"12","key":"1953_CR29","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","volume":"21","author":"JC Levy","year":"1998","unstructured":"Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses a computer program. Diabetes Care. 1998;21(12):2191\u20132.","journal-title":"Diabetes Care"},{"issue":"11","key":"1953_CR30","doi-asserted-by":"publisher","first-page":"e039804","DOI":"10.1136\/bmjopen-2020-039804","volume":"10","author":"C Huanan","year":"2020","unstructured":"Huanan C, Sangsang L, Amoah AN, Yacong B, Xuejiao C, Zhan S, et al. Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China. BMJ Open. 2020;10(11):e039804.","journal-title":"BMJ Open"},{"issue":"7785","key":"1953_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576(7785):51\u201360.","journal-title":"Nature"},{"issue":"2","key":"1953_CR32","doi-asserted-by":"publisher","first-page":"e0149614","DOI":"10.1371\/journal.pone.0149614","volume":"11","author":"Y Fan","year":"2016","unstructured":"Fan Y, Li X, Zhang Y, Fan X, Zhang N, Zheng H, et al. Genetic Variants of TPCN2 Associated with Type 2 Diabetes Risk in the Chinese Population. PLoS One. 2016;11(2):e0149614.","journal-title":"PLoS One"},{"key":"1953_CR33","doi-asserted-by":"publisher","first-page":"617628","DOI":"10.3389\/fendo.2021.617628","volume":"12","author":"L Xing","year":"2021","unstructured":"Xing L, Peng F, Liang Q, Dai X, Ren J, Wu H, et al. Clinical characteristics and risk of diabetic complications in data-driven clusters among type 2 diabetes. Front Endocrinol. 2021;12:617628.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1953_CR34","doi-asserted-by":"publisher","first-page":"e001506","DOI":"10.1136\/bmjdrc-2020-001506","volume":"8","author":"RM Anjana","year":"2020","unstructured":"Anjana RM, Baskar V, Nair ATN, Jebarani S, Siddiqui MK, Pradeepa R, et al. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study. BMJ Open Diabetes Res Care. 2020;8(1):e001506.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"1953_CR35","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2337\/db20-1054","volume":"70","author":"C Herder","year":"2021","unstructured":"Herder C, Maalmi H, Strassburger K, Zaharia OP, Ratter JM, Karusheva Y, et al. Differences in biomarkers of inflammation between novel subgroups of recent-onset diabetes. Diabetes. 2021;70(5):1198\u2013208.","journal-title":"Diabetes"},{"issue":"10","key":"1953_CR36","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.4103\/jfmpc.jfmpc_165_21","volume":"10","author":"A Chauhan","year":"2021","unstructured":"Chauhan A, Singhal A, Goyal P. TG\/HDL Ratio: A marker for insulin resistance and atherosclerosis in prediabetics or not? J Family Med Prim Care. 2021;10(10):3700\u20135.","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"1953_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12944-020-01403-7","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, Li G, Cheng T, Liu J, Song G, Ma H. Association between triglyceride-glucose index and risk of incident diabetes: a secondary analysis based on a Chinese cohort study: TyG index and incident diabetes. Lipids Health Dis. 2020;19(1):236.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"1953_CR38","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","volume":"93","author":"AC Vasques","year":"2011","unstructured":"Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98\u2013100.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1953_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2337\/dc14-1770","volume":"38","author":"L Liu","year":"2015","unstructured":"Liu L, Li X, Xiang Y, Huang G, Lin J, Yang L, et al. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care. 2015;38(1):16\u201321.","journal-title":"Diabetes Care"},{"issue":"6","key":"1953_CR40","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016;311(6):F1087\u2013108.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"1953_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.106.685628","volume":"116","author":"EL Barr","year":"2007","unstructured":"Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation. 2007;116(2):151\u20137.","journal-title":"Circulation"},{"key":"1953_CR42","doi-asserted-by":"crossref","unstructured":"Saatmann N, Zaharia OP, Strassburger K, Pesta DH, Burkart V, Szendroedi J, et al. Physical fitness and cardiovascular risk factors in the novel diabetes subgroups. J Clin Endocrinol Metab. 2022;107(4):1127\u201339.","DOI":"10.1210\/clinem\/dgab810"},{"issue":"9","key":"1953_CR43","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/dom.14063","volume":"22","author":"AR Kahkoska","year":"2020","unstructured":"Kahkoska AR, Geybels MS, Klein KR, Kreiner FF, Marx N, Nauck MA, et al. Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER, and SUSTAIN-6 cardiovascular outcomes trials. Diabetes Obes Metab. 2020;22(9):1537\u201347.","journal-title":"Diabetes Obes Metab"},{"issue":"7640","key":"1953_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385.","journal-title":"Nature"},{"issue":"2","key":"1953_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.semnephrol.2018.01.004","volume":"38","author":"F Afshinnia","year":"2018","unstructured":"Afshinnia F, Rajendiran TM, Wernisch S, Soni T, Jadoon A, Karnovsky A, et al. Lipidomics and Biomarker Discovery in Kidney Disease. Semin Nephrol. 2018;38(2):127\u201341.","journal-title":"Semin Nephrol"},{"key":"1953_CR46","doi-asserted-by":"publisher","first-page":"191382","DOI":"10.1155\/2015\/191382","volume":"2015","author":"R Crosby-Nwaobi","year":"2015","unstructured":"Crosby-Nwaobi R, Chatziralli I, Sergentanis T, Dew T, Forbes A, Sivaprasad S. Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy. J Diabetes Res. 2015;2015:191382.","journal-title":"J Diabetes Res"},{"issue":"4","key":"1953_CR47","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2337\/dc08-2011","volume":"32","author":"C Herder","year":"2009","unstructured":"Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, et al. Subclinical inflammation and diabetic polyneuropathy: MONICA\/KORA Survey F3 (Augsburg, Germany). Diabetes Care. 2009;32(4):680\u20132.","journal-title":"Diabetes Care"},{"issue":"11","key":"1953_CR48","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jnutbio.2015.05.005","volume":"26","author":"MY Li","year":"2015","unstructured":"Li MY, Wang YY, Cao R, Hou XH, Zhang L, Yang RH, et al. Dietary fish oil inhibits mechanical allodynia and thermal hyperalgesia in diabetic rats by blocking nuclear factor-\u03baB-mediated inflammatory pathways. J Nutr Biochem. 2015;26(11):1147\u201355.","journal-title":"J Nutr Biochem"},{"key":"1953_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cytogfr.2022.04.002","volume":"66","author":"D Gao","year":"2022","unstructured":"Gao D, Jiao J, Wang Z, Huang X, Ni X, Fang S, et al. The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment. Cytokine Growth Factor Rev. 2022;66:15\u201325.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"1953_CR50","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1007\/s00125-017-4385-1","volume":"60","author":"F Gerst","year":"2017","unstructured":"Gerst F, Wagner R, Kaiser G, Panse M, Heni M, Machann J, et al. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion. Diabetologia. 2017;60(11):2240\u201351.","journal-title":"Diabetologia"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01953-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01953-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01953-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T21:27:32Z","timestamp":1700602052000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01953-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1953"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01953-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]},"assertion":[{"value":"23 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Lanzhou University Second Hospital. The patients provided their informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}